Clinical Trial Update: Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel [Phase 3]

View source ↗

Summary

Phase 3 trial update showing equivalent efficacy and safety between biosimilar GP2015 and Enbrel (etanercept) in chronic plaque psoriasis. Results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ENBREL (etanercept)
• GP2015 (etanercept biosimilar)

Snippet

Sponsor: Sandoz | Conditions: Chronic Stable Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2017-03-27